Does Dementia Have a Microbial Cause?

Remi L Landry1,2, Monica E Embers1,2

  • 1Department of Tropical Medicine, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA; rlandry10@tulane.edu.

Neurosci
|November 1, 2024
PubMed

Insights

Pathogenic microbes may contribute to Alzheimer's disease (AD) by triggering brain inflammation and protein aggregation. This pathogen hypothesis suggests infections interact with genetics, but AD's exact cause remains elusive.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Pathology

Background:

  • Alzheimer's disease (AD) is a progressive neurocognitive disorder characterized by neuronal loss, synaptic dysfunction, amyloid-beta (Aβ) plaques, and neurofibrillary tangles.
  • The etiology of AD is complex and multifactorial, with ongoing research exploring various contributing factors.
  • The role of pathogenic microbes in neurodegenerative diseases like AD is an area of significant scientific interest.

Purpose of the Study:

  • To explore the potential contribution of pathogenic microbes to the development of dementia, specifically Alzheimer's disease.
  • To review evidence supporting the AD pathogen hypothesis, which posits that microbes can trigger AD pathogenesis.
  • To identify specific pathogens implicated in central nervous system (CNS) infections associated with AD.

Main Methods:

  • Review of observational, epidemiological, experimental, and pathological studies.
  • Examination of the AD pathogen hypothesis and its proposed mechanisms.
  • Identification of microbial agents found in the AD brain.

Main Results:

  • Evidence suggests a polymicrobial causality for dementia-inducing diseases.
  • Specific pathogens including *Borrelia* sp., HSV-1, VZV (HHV-2), HHV-6/7, oral pathogens, *Chlamydophila pneumoniae*, and *Candida albicans* have been detected in the CNS of AD patients.
  • These microbes can infect the CNS, evade immune responses, and persist in the AD brain.

Conclusions:

  • Pathogenic microbes may act as triggers in AD, interacting with genetic factors to initiate Aβ accumulation, hyperphosphorylated tau (p-tau), and neuroinflammation.
  • While significant progress has been made, the precise cause of Alzheimer's disease remains unclear.
  • Further research is warranted to elucidate the role of microbial infections in AD pathogenesis.

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
97
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
46
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
1.1K
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
452